We are proud to have earned a top score on the 2024 Disability Equality Index®, and to be recognized by Disability:IN as a #BestPlaceToWork24 for #DisabilityInclusion. Read the full news release: http://spr.ly/6048ikjig Learn more about how Labcorp is creating a culture of belonging: http://spr.ly/6049ikji9 #InclusiveWorkplace #DiversityAndInclusion #DisabilityPride #WorkplaceEquity
Labcorp
Hospitals and Health Care
Burlington, North Carolina 643,210 followers
In Pursuit of Answers
About us
Clear and confident health care decisions begin with questions. At Labcorp, we’re constantly in pursuit of answers. As a global leader of innovative and comprehensive laboratory services, we help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. We provide insights and advance science to improve health and improve lives through our unparalleled diagnostics and drug development laboratory capabilities. Our more than 60,000 employees serve clients in over 100 countries, worked on over 80% of the new drugs approved by the FDA in 2022 and performed more than 600 million tests for patients around the world. Learn more about Labcorp (NYSE: LH) at www.labcorp.com.
- Website
-
http://www.labcorp.com
External link for Labcorp
- Industry
- Hospitals and Health Care
- Company size
- 10,001+ employees
- Headquarters
- Burlington, North Carolina
- Type
- Public Company
Locations
-
Primary
531 South Spring Street
Burlington, North Carolina 27215, US
Employees at Labcorp
Updates
-
When a critical assay went down unexpectedly, Labcorp teams rallied behind a network-wide effort to find solutions and deliver results. Because these results would determine patient eligibility for enrollment in potentially life-saving clinical trials, Labcorp responded with urgency, using a patient-centric approach and cross-functional team collaboration. Learn how Labcorp’s global network of laboratories and industry-leading logistics team helped deliver the results on time: http://spr.ly/60419vzOc #ClinicalTrials #CentralLabs
-
We're pleased to share new #GeneTherapy research that provides critical knowledge to support adeno-associated virus (AAV)-mediated gene therapies. In this recent publication, Christos J. Petropoulos, vice president for Labcorp’s research and development, and Terri Wrin, technical director for Labcorp’s virology research and development, uncover the global seroprevalence of neutralizing antibodies against AAV serotypes crucial for human gene therapies. With data from 10 countries, this study provides valuable insights into the prevalence of neutralizing antibodies across different demographics. Explore the full research article to learn how these findings are shaping the future of clinical gene therapies: http://spr.ly/60469oeqs #AAVGeneTherapy #NAb
-
Labcorp's LGBTQ+ employee resource group, PRIDE, participated in events spanning from New Jersey to India. While Pride Month has come to a close, we are committed to improving health and improving lives for all communities. Join us as we look back on Labcorp's #Pride celebrations.
-
Labcorp India employees recently participated in the Run4Research initiative, organized by the Indian Society for Clinical Research. Clinical research is the backbone of medical advancements, and we're proud to support events like this that help raise awareness about its critical importance. #ClinicalResearch #Healthcare #Run4Research
-
Do you know when companion diagnostics (CDx) are needed for your cell and gene therapy programs? Or what kind of testing is required and how to choose the right lab partner for a CDx assay? In our blog, you’ll learn from Labcorp subject matter experts as they answer key questions you may have about developing CDx for your cell and gene therapy programs. Learn more: http://spr.ly/6046gLLLe #CellandGeneTherapy #CompanionDiagnostics
-
As Alzheimer’s & Brain Awareness Month comes to a close, we are taking time to reflect on the great progress in blood biomarker testing in Alzheimer’s while also acknowledging that there’s much more to do. Patients, caregivers and healthcare professionals deserve more, and Labcorp is actively working to deliver better access to tools that can improve health and improve lives. Learn more: http://spr.ly/6043gqcqV #ENDALZ #BloodBiomarkers #AlzheimersAwareness
-
Labcorp is proud to be named as one of TIME’s World’s Most Sustainable Companies of 2024. This recognition reflects our commitment to sustainable practices that positively impact the planet and is a testament to all that our employees do to help us create a healthier world. Read more about our sustainability initiatives in our 2023 Corporate Responsibility Report: http://spr.ly/6043gQAaP #Sustainability #SustainableFuture #CorporateResponsibility #WorldsMostSustainableCompanies2024
-
Labcorp Global Trial Connect brings digital, data and operational solutions that help accelerate study startup, streamline site workflows and integrate sample tracking with reliable data. We support you in bringing therapies to market faster. Discover Labcorp Global Trial Connect: http://spr.ly/6047glrAz #GlobalTrialConnect #ClinicalTrials #CentralLabs #InvestigatorSites
-
Read more from The Associated Press about our first trimester screening test to assess the risk of developing #preeclampsia, a high blood pressure disorder that can develop during #pregnancy or even occur postpartum: https://lnkd.in/grEGMpZ4 #MaternalHealth
Today an article by the Associated Press the Preeclampsia Foundation contributed on is talking about biomarkers for preeclampsia. "When you’re expecting a baby, you hope nothing goes wrong. But at least one in 20 people who are pregnant develop a scary complication called preeclampsia, a high blood pressure disorder that kills 70,000 women and 500,000 babies worldwide every year. There was no way to know when it might strike — until now. New blood tests may help doctors predict and manage this dangerous condition." New Thermo Fisher Scientific and Labcorp tests, with others on the way, are paving a new path to more tools in our toolboxes to care for patients with preeclampsia. Read more: https://lnkd.in/eJdVWpFf #preeclampsia #preeclampsiaawareness #preeclampsiafoundation #preeclampsiaresearch #hellpsyndrome #hellpsyndromeawareness #hellpsyndromesurvivor #eclampsia #eclampsiaawareness #eclampsiasurvivor #maternalhealth #pregnancy #postpartum #highriskpregnancy #postpartumpreeclampsia #postpartumpreeclampsiaawareness #postpartumpreeclampsiasurvivor #laboranddelivery #labornurse #maternalnurse #obgyn
Affiliated pages
Similar pages
Browse jobs
Stock
LH
NYSE
20 minutes delay
$216.50
9.01 (4.342%)
- Open
- 208.27
- Low
- 208.27
- High
- 216.72
Data from Refinitiv
See more info on